The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(3-(Benzyloxy)phenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-tert-butoxyacetic Acid ID: ALA4513683
PubChem CID: 56932431
Max Phase: Preclinical
Molecular Formula: C36H36FN3O5
Molecular Weight: 609.70
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc2cc(-c3cccc(OCc4ccccc4)c3)nn2c(-c2cc(F)c3c(c2C)CCCO3)c1C(OC(C)(C)C)C(=O)O
Standard InChI: InChI=1S/C36H36FN3O5/c1-21-26-15-10-16-43-33(26)28(37)18-27(21)32-31(34(35(41)42)45-36(3,4)5)22(2)38-30-19-29(39-40(30)32)24-13-9-14-25(17-24)44-20-23-11-7-6-8-12-23/h6-9,11-14,17-19,34H,10,15-16,20H2,1-5H3,(H,41,42)
Standard InChI Key: DVJQLVUSYHSWBD-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
33.0918 -17.3113 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8082 -16.8979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8054 -16.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0900 -15.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3770 -16.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3782 -16.0741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5947 -15.8223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1091 -16.4843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5926 -17.1519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2837 -16.4876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8729 -15.7709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0486 -15.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6343 -16.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0502 -17.2012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8730 -17.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5234 -17.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5184 -15.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2344 -16.0620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9473 -15.6468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2375 -16.8870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5152 -14.8271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2282 -14.4120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2251 -13.5870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9442 -14.8218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9379 -13.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0848 -14.8385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8032 -14.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7956 -13.5991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3707 -14.4322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3637 -13.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0791 -13.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0747 -12.3683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3566 -11.9538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6412 -12.3743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6439 -13.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5065 -13.1805 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.6593 -14.8499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6375 -15.0541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0515 -14.3404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6404 -13.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0572 -12.9166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6468 -12.2019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8209 -12.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4072 -12.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8200 -13.6304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
2 16 1 0
3 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
17 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
26 27 2 0
27 28 1 0
28 31 2 0
30 29 2 0
29 26 1 0
4 26 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
28 36 1 0
29 37 1 0
12 38 1 0
38 39 1 0
39 40 1 0
40 41 2 0
41 42 1 0
42 43 2 0
43 44 1 0
44 45 2 0
45 40 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 609.70Molecular Weight (Monoisotopic): 609.2639AlogP: 7.66#Rotatable Bonds: 8Polar Surface Area: 95.18Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.76CX Basic pKa: 1.31CX LogP: 7.55CX LogD: 4.27Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.19Np Likeness Score: -0.84
References 1. Li G, Meanwell NA, Krystal MR, Langley DR, Naidu BN, Sivaprakasam P, Lewis H, Kish K, Khan JA, Ng A, Trainor GL, Cianci C, Dicker IB, Walker MA, Lin Z, Protack T, Discotto L, Jenkins S, Gerritz SW, Pendri A.. (2020) Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors., 63 (5): [PMID:32081010 ] [10.1021/acs.jmedchem.9b01681 ]